Dextran is used more widely now-a-days because volume losses up to 1.5 liter can easily be replaced by erythrocyte-free fluids, as long as circulating volume and proper respiration are maintained and there is no preexisting anaemia. The use of blood and plasma must be limited to a minimum because of the risk of transmitting the hepatitis virus and of the other known disadvantages of blood and plasma transfusions. Furthermore, the volume effect of fresh plasma and thus of the plasma, component in banked blood, is not always a reliable one. Dextrans have, in addition, a definite antithrombotic effect without disturbing normal coagulation mechanisms in clinical dosages. 6% dextran 70 (Macrodex) in saline provides a long-lasting volume effect, corresponding to slightly more than the amount infused, whereas the 10% low molecular weight dextran 40 (Rhema-crodex) gives a very pronounced intitial volume increase, however, lasting less long. Rheomacro-dex improves flow and is used to counteract disturbances in the microcirculation. Dextran 70 is the replacement solution of choice for the initial treatment of hypovolemia of all etiologies and for routine use to cover moderate blood losses in elective surgery.